First Online: 26 July 2022
: O.S. holds patents on neutralization of histones and interference with chemokines in inflammation; receives funding from Novo Nordisk to study the role of histones in inflammation and to study chronopharmacological intervention strategies in atherosclerosis; and is on the scientific advisory board of ResoTher. A.R.T. is on the scientific advisory board of Tensixteen Bio and Beren Pharmaceuticals and is a consultant for Commonwealth Serum Laboratories.
Free to read: This content has been made available to all.